Kemp H. Kernstine, MD, PhD

home / authors / kemp-h-kernstine-md-phd

Articles

Benjamin Movsas, MD;Julie R. Brahmer, MD;Patrick M. Forde, MD;Kemp H. Kernstine, MD, PhD;Frederic W. Grannis, Jr, MD

June 1st 2016

This management guide for non–small-cell lung cancer (NSCLC) covers the symptoms, screening, diagnosis, staging, and treatment of adenocarcinoma, squamous cell carcinoma, and large-cell carcinoma of the lung.

Cancer Management Chapter 3: Non–small-cell lung cancer

Benjamin Movsas, MD;Fadlo R. Khuri, MD;Kemp H. Kernstine, MD, PhD

March 8th 2010

Lung cancer has been the leading cause of cancer death among men in the United States for years, and since 1988, it has become the number-one cause of cancer death among women. An estimated 219,440 new cases of lung cancer are expected in 2009, and 159,390 deaths due to this disease are expected to occur, roughly 30% of all cancer deaths. This exceeds the combined number of deaths from the leading causes of cancer (breast, prostate, and colon cancers). It accounts for 6% of all deaths in the United States.